Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vulvovaginal candidiasis.

Paul Nyirjesy1, Jack D Sobel

  • 1Department of Obstetrics and Gynecology, Drexel University College of Medicine, Philadelphia, PA, USA. pnyirjesy@comcast.net

Obstetrics and Gynecology Clinics of North America
|January 15, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotypic and genotypic analysis of <i>Candida albicans</i> vaginal isolates reveals that <i>ECE1</i> expression underpins pathogenicity.

Infection and immunity·2026
Same author

Sexual transmission of vaginal pathogens and male partner treatment: is it time to consider vulvovaginal candidiasis?

Sexually transmitted infections·2026
Same author

State-of-the-Art Review: Managing Vulvovaginal Candidiasis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Partner treatment in women with bacterial vaginosis: an update to the International Society for the Study of Vulvovaginal Disease (ISSVD) recommendations.

Sexually transmitted infections·2026
Same author

Elevated vaginal heparan sulfate correlates with impaired neutrophil killing of <i>Candida albicans</i> in women with vulvovaginal candidiasis.

Infection and immunity·2026
Same author

Methodologic and analytic considerations in the CANDLE trial of ibrexafungerp for recurrent vulvovaginal candidiasis (reply to letter to the editor).

American journal of obstetrics and gynecology·2026
Same journal

Bridging Science and Practice in Gender-Affirming Care: A Compendium for Gynecologists.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evidence, Clinical Expertise, and Research Gaps in Gender-Affirming Care.

Obstetrics and gynecology clinics of North America·2026
Same journal

Evaluation and Management of the Pediatric Gender-Diverse Patient.

Obstetrics and gynecology clinics of North America·2026
Same journal

Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.

Obstetrics and gynecology clinics of North America·2026
Same journal

Updates on Breast Cancer Screening and Special Considerations for Transgender Men and Women.

Obstetrics and gynecology clinics of North America·2026
Same journal

Contraceptive Needs of the Transmasculine Patient.

Obstetrics and gynecology clinics of North America·2026
See all related articles

Vulvovaginal candidiasis (VVC) is a spectrum of illness. While improved diagnostics and treatments are needed, most VVC patients can achieve symptom control, with home diagnostics potentially optimizing current therapies.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Women's Health

Background:

  • Vulvovaginal candidiasis (VVC) presents a range of clinical scenarios.
  • Current management strategies require optimization for improved patient outcomes.
  • There is a recognized need for advancements in both diagnostic tools and therapeutic options for VVC.

Purpose of the Study:

  • To highlight the spectrum of vulvovaginal candidiasis (VVC).
  • To emphasize the need for improved diagnostic modalities and novel treatment alternatives.
  • To discuss the potential of future advancements, such as home diagnostics, in optimizing VVC management.

Main Methods:

  • Review of current literature on VVC diagnostics and therapeutics.
  • Analysis of the spectrum of VVC disease presentation.

Related Experiment Videos

  • Exploration of potential future innovations in VVC management.

    • Main Results:

    • VVC encompasses a broad spectrum of disease severity.
    • Despite challenges, adequate symptom control is achievable for most VVC patients, including complicated cases.
    • Future advancements in diagnostics, particularly home-based testing, show promise for optimizing the use of existing VVC medications.

    Conclusions:

    • Most patients with VVC can achieve symptom control with current approaches.
    • Further research and development in diagnostic and therapeutic areas are crucial for advancing VVC care.
    • Home diagnostic tools may play a significant role in optimizing the management of VVC in the future.